logo

John Buse, MD

John Buse, MD

Endocrinology Chapel Hill, NC

Professor of Medicine, University of North Carolina School of Medicine

Office Address

Office Map
  • CB#7172, Burnett-Womack 8027
    160 Dental Circle
    Chapel Hill, NC 27599
    Phone: (919) 966-0134
    Fax: (919) 966-6025

Dr. Buse's Clinical Specialties & Interests

  • Endocrinology: Diabetes

Dr. Buse's Education & Medical Training

  • University of ChicagoUniversity of ChicagoFellowship, Endocrinology, Diabetes and Metabolism
  • University of ChicagoUniversity of ChicagoResidency, Internal Medicine
  • Duke Univ Sch of MedDuke University School of MedicineMedical School

Dr. Buse's Certifications & Licensure

  • NC State Medical LicenseNC State Medical License1994 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineEndocrinology, Diabetes and Metabolism

Dr. Buse's Awards, Honors, & Recognition

  • Consumers CheckbookTop MDConsumers Checkbook
  • Marquis Whos WhoWhos Who in Medicine and HealthcareMarquis Whos Who

Dr. Buse's Publications & Presentations

PubMed | Citations by Web of Science®

Lectures

  • Duke Regional Diabetes Symposium 2012Duke University School of Medicine, Kannapolis, North Carolina - 7/13/2012

Grant Support

  • Genome-Wide Association Study Of Accord Lipid Trial
    Genome-Wide Association Study Of Accord Lipid TrialNational Heart, Lung, And Blood Institute
    2012 - 2012
  • Clinical Trial: Action To Control Cardiovascular Risk In Diabetes Trial (ACCORD)
    Clinical Trial: Action To Control Cardiovascular Risk In Diabetes Trial (ACCORD)National Center For Research Resources
    2008 - 2008
  • NMR &Chemical Lipid Analysis In Patients With Type 2 Diabetes
    NMR &Chemical Lipid Analysis In Patients With Type 2 DiabetesNational Center For Research Resources
    2007 - 2007
  • Action To Control Cardiovascular Risk In Diabetes Trial (ACCORD)
    Action To Control Cardiovascular Risk In Diabetes Trial (ACCORD)National Center For Research Resources
    2007 - 2007
  • Akesis PRO Health PAK (Dietary Supplement) In NIDDM
    Akesis PRO Health PAK (Dietary Supplement) In NIDDMNational Center For Research Resources
    2000 - 2000
  • Rosiglitazone W/ Glyburide &Metformin In NIDDM PTS
    Rosiglitazone W/ Glyburide &Metformin In NIDDM PTSNational Center For Research Resources
    2000 - 2000
  • Troglitazone W/Sulfonylurea Or PLUS Metformin In NIDDM
    Troglitazone W/Sulfonylurea Or PLUS Metformin In NIDDMNational Center For Research Resources
    2000 - 2000
  • Atorvastatin As Compared To Simvastatin In Dyslipidemia
    Atorvastatin As Compared To Simvastatin In DyslipidemiaNational Center For Research Resources
    2000 - 2000
  • Atorvastatin As Prevention Of CHD In PTS W/ NIDDM
    Atorvastatin As Prevention Of CHD In PTS W/ NIDDMNational Center For Research Resources
    2000 - 2000
  • Effec Of A-100 On Glycemic Control In Overweight NIDDM
    Effec Of A-100 On Glycemic Control In Overweight NIDDMNational Center For Research Resources
    2000 - 2000
  • Effects Of Subcutaneous Administrated Ac2993 In NIDDM
    Effects Of Subcutaneous Administrated Ac2993 In NIDDMNational Center For Research Resources
    2000 - 2000
  • Gennid--Genetics Of Non-Insulin-Dependent Diabetes
    Gennid--Genetics Of Non-Insulin-Dependent DiabetesNational Center For Research Resources
    2000 - 2000
  • Glucagon Receptor Antagonist BAY 27-9955 In NIDDM
    Glucagon Receptor Antagonist BAY 27-9955 In NIDDMNational Center For Research Resources
    2000 - 2000
  • Pimagedine In Diabetic PTS W/ Overt Diabetic Nephropathy
    Pimagedine In Diabetic PTS W/ Overt Diabetic NephropathyNational Center For Research Resources
    2000 - 2000
  • 570x As Monotherapy For Subjects W/ Type 2 Diabetes
    570x As Monotherapy For Subjects W/ Type 2 DiabetesNational Center For Research Resources
    1999 - 2002
  • Insulin Delivery Using New Lilly 3 0 ML Disposable Pen Device
    Insulin Delivery Using New Lilly 3 0 ML Disposable Pen DeviceNational Center For Research Resources
    1999 - 2002
  • Metformin/Glyburide As 1st LINE Therapy In Type 2 Diabetes
    Metformin/Glyburide As 1st LINE Therapy In Type 2 DiabetesNational Center For Research Resources
    1999 - 2002
  • Oral Gi262570x In Patients W/ Type 2 Diabetes Mellitus
    Oral Gi262570x In Patients W/ Type 2 Diabetes MellitusNational Center For Research Resources
    1999 - 2002
  • Zenarestat (Ci 1014) In Treatment Of Diabetic Neuropathy
    Zenarestat (Ci 1014) In Treatment Of Diabetic NeuropathyNational Center For Research Resources
    1999 - 2002
  • Trial Comparing HOE 901 &Nph Human Insulin Subjects W/ Type I Diabet
    Trial Comparing HOE 901 &Nph Human Insulin Subjects W/ Type I DiabetNational Center For Research Resources
    1999 - 2002
  • Niaspan In Type 2 Diabetic Patients W/ Dyslipidemia
    Niaspan In Type 2 Diabetic Patients W/ DyslipidemiaNational Center For Research Resources
    1999 - 2002
  • Atorvastatin As Secondary Prevention Of Coronary Heart Disease
    Atorvastatin As Secondary Prevention Of Coronary Heart DiseaseNational Center For Research Resources
    1998 - 2002
  • Clinical Trial Comparing HOE 901 Insulin With NPH Human Insulin Type I
    Clinical Trial Comparing HOE 901 Insulin With NPH Human Insulin Type INational Center For Research Resources
    1998 - 2002
  • Comparison Of Human Insulin Analogue X14 In Type I Diabetes
    Comparison Of Human Insulin Analogue X14 In Type I DiabetesNational Center For Research Resources
    1998 - 2002
  • Efficacy Trial Of Voglibose (A)-1128 2 MG In Type II Diabetes
    Efficacy Trial Of Voglibose (A)-1128 2 MG In Type II DiabetesNational Center For Research Resources
    1998 - 2002
  • 54 Week OPEN Label Assessment Of Safety/Efficacy Of Atorvastatin/Simvastatin
    54 Week OPEN Label Assessment Of Safety/Efficacy Of Atorvastatin/SimvastatinNational Center For Research Resources
    1998 - 2002
  • 24-Week Double-Blind Study Of Troglitazone
    24-Week Double-Blind Study Of TroglitazoneNational Center For Research Resources
    1998 - 2002
  • Clinical Trial Comparing HOE 901 Insulin With NPH Human Insulin In NIDDM
    Clinical Trial Comparing HOE 901 Insulin With NPH Human Insulin In NIDDMNational Center For Research Resources
    1998 - 2002
  • D-Chiro-Inositol, Pinitol And Myoinositol Concentrations In Diabetic Patients
    D-Chiro-Inositol, Pinitol And Myoinositol Concentrations In Diabetic PatientsNational Center For Research Resources
    1997 - 1999
  • Pimagedine In Patient With Type II Diabetes And Overt Diabetic Nephropathy
    Pimagedine In Patient With Type II Diabetes And Overt Diabetic NephropathyNational Center For Research Resources
    1997 - 2002
  • Protect-Procose (Acarbose Tablets)--Diabetes
    Protect-Procose (Acarbose Tablets)--DiabetesNational Center For Research Resources
    1997 - 1997
  • Troglitazone VS Placebo In Noninsulin Dependent Diabetes Mellitus
    Troglitazone VS Placebo In Noninsulin Dependent Diabetes MellitusNational Center For Research Resources
    1997 - 2002
  • Diabetes Prevention Trial Of Type I Diabetes
    Diabetes Prevention Trial Of Type I DiabetesNational Center For Research Resources
    1997 - 1999
  • Troglitazone (Ci-991) In Patients With NIDDM
    Troglitazone (Ci-991) In Patients With NIDDMNational Center For Research Resources
    1996 - 1997
  • Aminoguanidine In Diabetic Patients With Overt Diabetic Nephropathy
    Aminoguanidine In Diabetic Patients With Overt Diabetic NephropathyNational Center For Research Resources
    1996 - 2002
  • Metabolic And Genetic Screening Of Families With Diabetes
    Metabolic And Genetic Screening Of Families With DiabetesNational Center For Research Resources
    1996 - 1997
  • Double Blind Study Of Troglitazone (Ci-991)
    Double Blind Study Of Troglitazone (Ci-991)National Center For Research Resources
    1996 - 1996

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
  • BCBS Illinois BlueChoice Select
  • BCBS Illinois PPO
  • BCBS North Carolina BlueOptions PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Choice
  • First Health PPO
  • Great West PPO
  • Health Alliance PPO
  • Health Net Oregon PPO
  • HealthLink PPO
  • Humana ChoiceCare Network PPO
  • ODS Network
  • Providence Health System Personal Option
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Buse's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV